5-Fluorouracil and Weekly Oxaliplatin Combined with Radiotherapy for Locally Advanced Rectal Cancer: Surgical Complications and Long-term Results

2006 ◽  
Vol 37 (7) ◽  
pp. 860-865 ◽  
Author(s):  
Salvatore Pucciarelli ◽  
Emanuele Urso ◽  
Gian Luca DeSalvo ◽  
Carlo Aschele ◽  
Maria Luisa Friso ◽  
...  
2018 ◽  
Vol 24 (4) ◽  
pp. 403-410 ◽  
Author(s):  
Akihiro Tomida ◽  
◽  
Keisuke Uehara ◽  
Kazuhiro Hiramatsu ◽  
Atsuyuki Maeda ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-8 ◽  
Author(s):  
M. Kripp ◽  
K. Horisberger ◽  
S. Mai ◽  
P. Kienle ◽  
T. Gaiser ◽  
...  

Purpose. The addition of cetuximab to radiochemotherapy (RCT) failed to improve complete response rates in locally advanced rectal cancer (LARC). We report the long-term results in patients treated within two sequential clinical trials.Methods. Patients receiving neoadjuvant RCT using capecitabine and irinotecan (CapIri) within a phase I/II trial or CapIri + cetuximab within a phase II trial were evaluated for analysis of disease-free survival (DFS) and overall survival (OS). KRAS exon 2 mutational status had been analyzed in patients receiving cetuximab.Results. 37 patients from the CapIri trial and 49 patients from the CapIri-cetuximab treatment group were evaluable. Median follow-up time was 75.2 months. The 5-year DFS rate was 82% (CapIri) and 79% (CapIri-cetuximab)(P=0.62). The median OS was 127.4 months. 5-year OS was 73% for both groups (CapIri and CapIri-cetuximab)(P=0.61). No significant difference in DFS(P=0.86)or OS(P=0.39)was noticed between patients receiving CapIri and those receiving CapIri-cetuximab with KRAS wild-type tumors.Conclusions. As the addition of cetuximab did not improve neither DFS nor OS it should not play a role in the perioperative treatment of patients with LARC, not even of patients with (K)RAS WT tumors.


2013 ◽  
Vol 56 (3) ◽  
pp. 281-287 ◽  
Author(s):  
Ninos Ayez ◽  
Jacobus W. A. Burger ◽  
Anne E. van der Pool ◽  
Alexander M. M. Eggermont ◽  
Dirk J. Grunhagen ◽  
...  

2017 ◽  
Vol 35 (4_suppl) ◽  
pp. 670-670
Author(s):  
Thilo Sprenger ◽  
Tim Beissbarth ◽  
Rainer Fietkau ◽  
Hans-Rudolf Raab ◽  
Werner Hohenberger ◽  
...  

670 Background: The influence of major surgical complications on survival in patients with locally advanced rectal cancer undergoing combined modality treatment is still debatable. The aim of this study was to evaluate the impact of surgical complications on oncological outcome in 823 patients with locally advanced rectal cancer treated within the phase III CAO/ARO/AIO-94 trial. Methods: Anastomotic leakages as well as wound healing disorders were prospectively evaluated and correlated with overall survival (OS) and the cumulative incidence of distant metastasis and local recurrence after a long-term follow-up of more than 10 years. Results: Anastomotic leakage after restorative rectal resection is significantly correlated with an impaired 10-year OS (51.0% vs. 65.2%, p = 0.02). Patients with abdominal or sacral wound healing disorders had a significantly reduced OS compared to those with sufficient wound healing (45.2% vs. 62.7%, p = 0.009). Patients developing any surgical complication (anastomotic leakage or/and wound healing disorder) had an impaired OS (50.6% vs 65.3%, p = 0.0002) as well as higher rates of distant metastases (65.3% vs. 72.7%, p = 0.03) and local recurrences (6.0% vs. 12.9%, p = 0.0007). In a multivariate cox regression model the only independent factors for restricted OS were lymph node metastases (p < 0.0001) and the occurrence of surgical complications (p = 0.008). Conclusions: Surgical complications are significantly associated with an adverse oncological outcome and reduced long-term OS in patients undergoing combined modality treatment for locally advanced rectal cancer.


2020 ◽  
Vol 39 (3) ◽  
pp. 56-59
Author(s):  
Sergey A. Alentyev ◽  
Oleg A. Litvinov ◽  
Evgeniy V. Zhitikhin ◽  
Igor E. Onnitsev ◽  
Igor G. Ignatovich ◽  
...  

The clinical observation the results of combined treatment of a patient with locally advanced rectal cancer complicated by bleeding with the use of selective chemooil embolization of the superior rectal artery have been presented (1 figure, bibliography: 4 refs).


Sign in / Sign up

Export Citation Format

Share Document